Morgan Stanley maintains Overweight rating on Exelixis with PT down to $46.

Morgan Stanley maintains Overweight rating on Exelixis with PT down to $46.

Wall Street analysts have recently revised their price targets and ratings for several major U.S. companies, reflecting changes in market sentiment and corporate performance. Here are some key updates:

- Cadence Design Systems (CDNS): JP Morgan raised its price target to $390 from $330, while Deutsche Bank increased it to $361 from $345. Mizuho and Needham also updated their targets, with Mizuho setting it at $375 and Needham at $390.
- Blackline (BL): Raymond James upgraded its rating to "outperform" from "market perform."
- Coinbase Global (COIN): Jefferies raised its price target to $405 from $260, while Citigroup increased it to $505 from $270.
- Disney (DIS): JP Morgan raised its price target to $138 from $130.
- Kinsale Capital Group (KNSL): Jefferies increased its price target to $490 from $480.

Other notable updates include:

- Advanced Micro Devices (AMD): BofA Global Research raised its price target to $200 from $175.
- Amazon (AMZN): Stifel and Wells Fargo both increased their price targets, with Stifel setting it at $262 and Wells Fargo at $245.
- Aris Water Solutions (ARIS): JP Morgan initiated coverage with a neutral rating and a price target of $25.
- Autonation (AN): Stephens raised its price target to $200 from $190.
- Baker Hughes (BKR): Morgan Stanley increased its target price to $55 from $45.
- Banc of California (BANC): Wells Fargo raised its price target to $18 from $16.
- Brookfield Asset Management (BAM): National Bank of Canada initiated coverage with an "outperform" rating and a price target of $71.
- Brown & Brown (BRO): Barclays reduced its price target to $108 from $111.
- Campbell's (CPB): Stifel lowered its price target to $34 from $38.
- Carter's (CRI): Barclays reduced its price target to $22 from $25.
- Celcuity (CELC): H.C. Wainwright, Jefferies, and Needham all increased their price targets, with Needham setting it at $74.
- Centene (CNC): Deutsche Bank, Jefferies, and JP Morgan all reduced their price targets, with Deutsche Bank setting it at $24.
- Centerpoint Energy (CNP): Barclays raised its price target to $39 from $38.
- CF Industries (CF): JP Morgan increased its price target to $92 from $75 and changed its rating to neutral from underweight.
- Charles Schwab (SCHW): Morgan Stanley raised its price target to $131 from $117.
- Chipotle (CMG): BofA Global Research removed the stock from its US 1 list.
- Cincinnati Financial (CINF): Roth MKM increased its price target to $175 from $160.
- Clorox (CLX): Deutsche Bank reduced its price target to $137 from $146.
- Columbia Banking System (COLB): Barclays and Wells Fargo both increased their price targets, with Wells Fargo setting it at $28.
- Crown Castle (CCI): Barclays raised its price target to $121 from $117.
- Customers Bancorp (CUBI): Stephens increased its price target to $62 from $55.
- Domino's Pizza (DPZ): RBC reduced its price target to $500 from $550 and changed its rating to "sector perform" from "outperform."
- Doordash (DASH): Stifel and Truist Securities both increased their price targets, with Truist Securities setting it at $272.
- Dyne Therapeutics (DYN): Chardan Capital Markets and Raymond James both reduced their price targets.
- eBay (EBAY): BofA Global Research and Stifel both increased their price targets, with BofA Global Research setting it at $82.
- Elanco Animal Health (ELAN): Morgan Stanley raised its price target to $15 from $10.
- Equity Lifestyle Properties (ELS): Barclays reduced its price target to $67 from $70.
- Etsy (ETSY): Stifel increased its price target to $66 from $45.
- Exelixis (EXEL): Morgan Stanley and Stifel both reduced their price targets, with Stifel setting it at $41.
- Fiserv (FI): Mizuho and Truist Securities both reduced their price targets.
- General Dynamics (GD): Barclays raised its price target to $350 from $285.
- Gentex (GNTX): JP Morgan increased its price target to $30 from $26.
- Globe Life (GL): KBW raised its price target to $160 from $155.
- Harmonic (HLIT): Barclays reduced its price target to $8 from $10.
- Healthpeak Properties (DOC): Scotiabank reduced its price target to $19 from $21 and changed its rating to "sector perform" from "sector outperform."
- Hershey (HSY): Stifel increased its price target to $180 from $160.
- Hexcel (HXL): BMO and Deutsche Bank both increased their price targets, with Deutsche Bank setting it at $61.
- Idexx Laboratories (IDXX): Morgan Stanley raised its target to $626 from $558.
- Ionq (IONQ): Rosenblatt Securities initiated coverage with a "buy" rating and a price target of $70.
- Iqvia (IQV): Deutsche Bank increased its price target to $220 from $200.
- Iridium Communications (IRDM): Barclays reduced its price target to $31 from $38.
- J M Smucker (SJM): Stifel increased its price target to $110 from $106.
- Kforce (KFRC): Truist Securities reduced its price target to $46 from $50.
- Kinsale Capital Group (KNSL): BMO and Jefferies both increased their price targets.
- Knife River Corporation (KNF): Wells Fargo reduced its price target to $96 from $114.
- Kratos (KTOS): Truist Securities increased its price target to $78 from $52.
- L3Harris Technologies (LHX): Barclays raised its price target to $305 from $255.
- Lam Research (LRCX): Stifel increased its price target to $110 from $92.
- Lantheus Holdings (LNTH): Leerink Partners reduced its price target to $134 from $137.
- Liberty Energy (LBRT): Barclays reduced its price target to $14 from $16.
- Life360 (LIF): Stifel increased its price target to $87 from $48.
- McCormick (MKC): Stifel reduced its price target to $76 from $82.
- Merchants Bancorp (MBIN): Morgan Stanley reduced its price target to $34 from $40.
- MGM Resorts (MGM): Susquehanna increased its price target to $60 from $50.
- Mntn (MMNTN): Citizens increased its price target to $30 from $23.
- Mohawk Industries (MHK): Jefferies increased its price target to $134 from $115.
- Molina Healthcare (MOH): JP Morgan reduced its price target to $184 from $272.
- Nextracker (NXT): Roth MKM increased its price target to $80 from $70.
- Northrop Grumman (NOC): Barclays raised its price target to $580 from $500.
- PayPal (PYPL): Monness Crespi Hardt increased its price target to $105 from $95.
- Petmed Express (PETS): Morgan Stanley reduced its price target to $3 from $3.20.
- Pinnacle Financial Partners (PNFP): Stephens reduced its price target to $104 from $133.
- PTC Therapeutics (PTCT): Barclays, BofA Global Research, Jefferies, Truist Securities, and Wells Fargo all increased their price targets, with Wells Fargo setting it at $78.
- Qualys (QLYS): Jefferies increased its price target to $140 from $135.
- Rambus (RMBS): Jefferies and Sus